Exemplos de uso de Systemic exposure levels em Inglês e suas traduções para o Português
{-}
-
Medicine
-
Colloquial
-
Official
-
Financial
-
Ecclesiastic
-
Ecclesiastic
-
Computer
-
Official/political
Animal studies are insufficient, buthave shown reproductive toxicity at high systemic exposure levels see section 5.3.
These effects occurred at systemic exposure levels that are equivalent to or less than the clinical exposure at the recommended dose of 2 g/day.
In pregnant rabbits, opicapone was less well tolerated resulting in maximum systemic exposure levels around or below the therapeutic range.
These effects occurred at systemic exposure levels that are equivalent to or less than the clinical exposure at the recommended dose of 2 g/day for renal transplant recipients.
In animal studies formoterol has caused adverse reactions in reproduction studies at very high systemic exposure levels see section 5.3.
Gastrointestinal effects were observed in the dog at systemic exposure levels equivalent to or less than the clinical exposure at the recommended doses.
In addition, very slight to slight skeletal muscle degeneration was also observed histologically at doses resulting in systemic exposure levels of approximately 23 times.
Studies in animals have shown reproductive toxicity at systemic exposure levels(AUC) of duloxetine lower than the maximum clinical exposure see section 5.3.
In vitro investigations have indicated that indacaterol has negligible potential to cause metabolic interactions with medicinal products at the systemic exposure levels achieved in clinical practice.
Studies in rodents produced species-specific abortion at systemic exposure levels 33- to 97-times that achieved in humans after ocular administration.
Regarding reproduction toxicity of entacapone, decreased foetal weight anda slightly delayed bone development were noticed in rabbits treated at systemic exposure levels in the therapeutic range.
The majority of the effects in repeat-dose toxicity studies appeared at systemic exposure levels which are equivalent to or even below the human exposure levels at the recommended clinical dose.
Studies in animals have shown fetotoxicity only at dose levels much higher than the maximum human exposure to aclidinium andadverse effects in reproduction studies with formoterol at very high systemic exposure levels see section 5.3.
Laropiprant was not teratogenic in rats or in rabbits at systemic exposure levels at least 153 and 438 times the human exposure based on the AUC of the recommended daily human dose.
In pre/postnatal toxicity study in the rat,duloxetine induced adverse behavioural effects in the offspring at systemic exposure levels below maximum clinical exposure AUC.
This administration corresponds to free active substance systemic exposure levels of at least 9 times the expected levels in human after 1 month and less than the expected level in humans after 6 months, respectively.
In rats, there was an increased incidence of hepatic adenomas and carcinomas at systemic exposure levels 58 times the human exposure level.
These findings were generally observed at systemic exposure levels within the range of therapeutic exposure or above, with the exception of the findings in rats, which occurred below therapeutic exposure due to a high tissue distribution.
Gastrointestinal and renal effects consistent with dehydration were also observed in the monkey at the highest dose systemic exposure levels equivalent to or greater than clinical exposure. .
However, in repeated- dose toxicity studies performed in rats and monkeys, effects on female fertility were observed in the form of follicular atresia, degeneration of corpora lutea, endometrial changes in the uterus anddecreased uterine and ovarian weights at clinically relevant systemic exposure levels.
In addition, very slight to slight skeletal muscle degeneration was also observed histologically at doses resulting in systemic exposure levels of approximately 23 times the human exposure level.
At the no-effect level for these findings, systemic exposure levels(AUC) were, in rats, approximately 1.5-fold the expected human exposure levels in females and 0.8-fold in males, and in mice, approximately 0.8-fold the expected human exposure levels in both males and females.
No evidence of impaired fertility was seen in other studies when either male or female rats were treated at doses up to 2000 mg/kg/day andmated with untreated rats systemic exposure levels approximately 6-14 times higher than those achieved in humans.
Increases in serum alanine aminotransferase(ALT)levels were observed in all dog studies, at systemic exposure levels at least 14 times the human exposure based on the AUC of the recommended daily human dose.
In reproductive and developmental toxicity studies in rodents and rabbits, no teratogenic effects but an increase in numbers of stillborn pups and pup deaths in the peripartum period, and slightly reduced live litter sizes andpup body weights were observed at maternal toxic doses in rats corresponding to systemic exposure levels similar to the expected clinical exposure. .
In peri and post-natal studies in rats, dystocia, increased foetal deaths in utero and toxicity to post-natal development(pup body weight and development land marks)were observed at systemic exposure levels up to 11 times the AUC0-24h of free plasma concentration at MRHD.
In peri and post natal studies in rats, dystocia, increased foetal deaths in utero, and toxicity to post natal development(pup body weight and development land marks)were observed at systemic exposure levels up to 11 times higher than the expected clinical exposure. .
Reproductive toxicity studies showed a slight treatment-related increased incidence of fetal rib malformations(absent, hypoplastic and wavy ribs)in the offspring of rats at systemic exposure levels more than 29 times the human exposure levels. .
Reproductive toxicity studies showed a slight treatment-related increased incidence of foetal rib malformations(absent, hypoplastic and wavy ribs)in the offspring of rats at systemic exposure levels more than 29 times the human exposure levels. .
Reproduction toxicity studies showed slight treatment-related decreases in mean maternal weight gain and foetal body weight, slight increases in pup mortality, and increased incidence of supernumerary rib andincomplete ossification of the sternebra in the foetus were observed in rats at systemic exposure levels at least 513 times the human exposure based on the AUC of the recommended daily human dose.